Actual Medicinal Product (AMP) Ipinnia XL 4mg tablets (Ethypharm UK Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible logo Suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

No special requirements for storage.

Provenance

This compatibility recommendation is derived from Raponer XL tablets (Accord Healthcare Ltd).

Generic
Ropinirole
Formulation
Ropinirole 4mg modified-release tablets
  • Ropinirole
    • Ropinirole 4mg modified-release tablets

      • Ipinnia XL 4mg tablets (Ethypharm UK Ltd)

Alternative Suppliers (17)

compatible logo ReQuip XL 4mg tablets (GlaxoSmithKline UK Ltd)
compatible logo ReQuip XL 4mg tablets (Sigma Pharmaceuticals Plc)
compatible logo ReQuip XL 4mg tablets (Necessity Supplies Ltd)
compatible logo ReQuip XL 4mg tablets (DE Pharmaceuticals)
compatible logo Ralnea XL 4mg tablets (Krka UK Ltd)
compatible logo Repinex XL 4mg tablets (Aspire Pharma Ltd)
compatible logo Raponer XL 4mg tablets (Accord-UK Ltd)
compatible logo Ipinnia XL 4mg tablets (Ethypharm UK Ltd)
compatible logo Ropiqual XL 4mg tablets (Milpharm Ltd)
compatible logo Ropinirole 4mg modified-release tablets (Krka UK Ltd)
compatible logo ReQuip XL 4mg tablets (Waymade Healthcare Plc)
compatible logo ReQuip XL 4mg tablets (Mawdsley-Brooks & Company Ltd)
compatible logo Spiroco XL 4mg tablets (Teva UK Ltd)
compatible logo Aimpart XL 4mg tablets (Zentiva Pharma UK Ltd)
compatible logo Ropinirole 4mg modified-release tablets (Colorama Pharmaceuticals Ltd)
compatible logo Ropilynz XL 4mg tablets (Lupin Healthcare (UK) Ltd)
compatible logo Ropinirole 4mg modified-release tablets (Viatris UK Healthcare Ltd)